A Druggable Tumor Suppressor and Leukemic Stem Cell Marker
Pan, Y.; Wang, C.; Meng, X.; Zhou, W.; Hammer, R.; Zheng, H.; Hildebrandt, G.; Kang, X.
Show abstract
Withdrawal StatementThe authors have withdrawn this preprint because the co-authors were not in agreement about posting the work in its current form. The authors request that this work not be cited. Please contact the corresponding author (Dr. Xunlei Kang, kangxu@health.missouri.edu) with questions.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia 98%
- Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition 98%
- A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy 98%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML 99%
- Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties 98%
- Resistance to decitabine and 5-azacytidine emerges from adaptive responses of the pyrimidine metabolism network 97%
Similar papers in this journal
- Signatures of immune senescence predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia 97%
- Germline RUNX1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia 96%
- Antibody-drug conjugates targeting CD45 plus Janus kinase inhibitors effectively condition for allogeneic hematopoietic stem cell transplantation 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.